Acorda Therapeutics Inc (ACORQ) Return on Equity ROE from the first quarter 2024 to first quarter 2023 and annually, average high and low, overall ranking from Mar 31 2024 to Mar 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Acorda Therapeutics Inc   (ACORQ)

Acorda Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Acorda Therapeutics Inc in the first quarter 2024?
Due to the lack of equity, it was not possible to calculate Acorda Therapeutics Inc 's return on equity (ROE) in its first quarter 2024

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Equity Change - - -22.19 % -22.8 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -263 -253 -16 -21 -58
Return On Equity (TTM) - -2206.93 % -21.45 % -26.63 % -69.67 %
ACORQ's Total Ranking # 3990 # 0 # 0 # 0 #
Equity (TTM) in Millions -186 -158 59 68 77
Seq. Equity Change - - -13.13 % -11.81 % -17.8 %
Seq. Net Income Change - - - - -

Back to ACORQ Management Effectiveness >> ACORQ's 5 Years Annual ROE >> Compare ACORQ ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 122
Sector # 810
Overall # 3990

Return On Equity Statistics
High Average Low
35.61 %
-57.13 %
-1387.54 %
(Sep 30 2013)   (Mar 31 2024)





ACORQ Annual Return On Equity (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Equity in Millions -158 94 151 238 311
Y / Y Equity Change - -38.05 % -36.49 % -23.44 % -49.21 %
Net Income in Millions -253 -66 -104 -100 -273
Y / Y Net Income Change - - - - -
Return On Equity - -70.41 % -68.78 % -41.85 % -87.82 %

Back to ACORQ Management Effectiveness >> ACORQ's 5 Years Annual ROE >> Compare ACORQ ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ACORQ's' Return on Equity at Yahoo Finance
ACORQ's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ACORQ's Competitors
Subscribers only: Roe for Acorda Therapeutics Inc 's Suppliers
Subscribers only: Return On Equity for ACORQ's Customers




Companies with similar Return On Equity at Mar 31 2024, within Healthcare Sector ROE
Hca Healthcare Inc   806.86 %
Biomx Inc  595.88 %
Cardiff Lexington Corporation  552.36 %
Ir med Inc   481.97 %
Merrimack Pharmaceuticals Inc  288.18 %
WEED, INC.  249.65 %
Ladrx Corporation  207.75 %
Glucotrack Inc   207.15 %
Halozyme Therapeutics Inc   192.68 %
Scynexis Inc   122.03 %
Viskase Holdings inc   118.99 %
Mimedx Group Inc   116.14 %
Roivant Sciences Ltd   107.85 %
Entera Bio Ltd   103.40 %
Tenet Healthcare Corp  98.05 %

Date modified: 2026-09-26T07:16:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.